ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79 | -32.5% | 24,801 | +5.4% | 0.00% | 0.0% |
| Q2 2023 | $117 | -11.4% | 23,521 | -11.8% | 0.00% | 0.0% |
| Q1 2023 | $132 | -18.5% | 26,655 | +3.4% | 0.00% | 0.0% |
| Q4 2022 | $162 | -99.9% | 25,790 | -8.3% | 0.00% | -50.0% |
| Q3 2022 | $304,000 | +112.6% | 28,115 | +123.6% | 0.00% | +100.0% |
| Q2 2022 | $143,000 | -2.1% | 12,572 | -21.5% | 0.00% | 0.0% |
| Q1 2022 | $146,000 | -34.2% | 16,022 | +7.5% | 0.00% | 0.0% |
| Q4 2021 | $222,000 | -30.6% | 14,898 | +19.6% | 0.00% | -50.0% |
| Q3 2021 | $320,000 | +56.9% | 12,460 | +59.4% | 0.00% | +100.0% |
| Q2 2021 | $204,000 | -12.1% | 7,815 | +18.8% | 0.00% | 0.0% |
| Q1 2021 | $232,000 | -72.4% | 6,580 | -70.5% | 0.00% | -80.0% |
| Q3 2020 | $840,000 | – | 22,284 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |